AQUESTIVE THERAPEUTICS INC. - COMMON STOCK

Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ET

05 3月 2021 07:00:00 条件 Nasdaq GlobeNewswire

Aquestive Therapeutics Reaffirms Near-Term NDA Resubmission for Libervant™ (diazepam) Buccal Film Following FDA Feedback

25 2月 2021 07:30:00 条件 Nasdaq GlobeNewswire

Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET

17 2月 2021 07:30:00 条件 Nasdaq GlobeNewswire

Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

09 2月 2021 07:30:00 条件 Nasdaq GlobeNewswire

Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy

28 1月 2021 07:30:00 条件 Nasdaq GlobeNewswire

Aquestive Therapeutics Provides Business Update

07 1月 2021 07:30:00 条件 Nasdaq GlobeNewswire

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

04 1月 2021 07:30:00 条件 Nasdaq GlobeNewswire